comparemela.com
Home
Live Updates
Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore : comparemela.com
Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore
This deal also marks the entry of Eris into the RoW Export Markets.
Related Keywords
India ,
Australia ,
Switzerland ,
United States ,
Australian ,
America ,
Swiss ,
Amit Bakshi ,
Biocon Biologics ,
Asia Pacific ,
Eris Lifesciences Ltd ,
Swiss Parenterals Ltd ,
Promoter Group ,
Eris Lifesciences ,
Swiss Parenterals ,
Row Export ,
Injectables Focused Branded Formulations ,
Managing Director ,
Redeemable Non Convertible Debentures ,
Brazilian Anvisa ,
Mexican Cofepris ,
Eris Lifescines ,
Chris ,
M A ,
comparemela.com © 2020. All Rights Reserved.